Stroke pharmacogenomics

AMR Billeci, G Agnelli, V Caso - Expert Opinion on …, 2009 - Taylor & Francis
Circulatory disease accounts for fifteen million deaths each year, of which stroke accounts
for four and a half million-with an estimated nine million stroke survivors annually. The …
被引用次数：12 相关文章

Stroke pharmacogenomics

AMR Billeci, G Agnelli, V Caso - Expert opinion on …, 2009 - pubmed.ncbi.nlm.nih.gov
Circulatory disease accounts for fifteen million deaths each year, of which stroke accounts
for four and a half million-with an estimated nine million stroke survivors annually. The …

[引用][C] Stroke pharmacogenomics.

A Billeci, G Agnelli, V Caso - EXPERT OPINION ON …, 2009 - research.unipg.it

Stroke pharmacogenomics.

AM Billeci, G Agnelli, V Caso - Expert Opinion on Pharmacotherapy, 2009 - europepmc.org
Circulatory disease accounts for fifteen million deaths each year, of which stroke accounts
for four and a half million-with an estimated nine million stroke survivors annually. The …